The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify biomarkers of Parkinson’s disease well in advance of symptoms appearing. The initiative could lead to new diagnostic tools and ways of slowing or stopping the condition’s progression.Continue ReadingCategory: Illnesses and conditions, Body & MindTags: Parkinson's Disease, Biomarkers, Plasma

Grifols inicia un estudi per detectar precoçment el Parkinson a partir del plasma

El Punt Avui

Grifols initiates a study to detect Parkinson's early using plasma

Grifols today announced the start of a pioneering study to detect early signs of Parkinson's through the analysis of plasma samples. This is the Chronos-PD project, made possible thanks to...

Grifols ha anunciat avui l’inici d’un estudi pioner per detectar signes primerencs del Parkinson mitjançant l’anàlisi de mostres de plasma. Es tracta del projecte Chronos-PD, possible gràcies...

New Atlas

Michael J. Fox funds early warning Parkinson's biomarker initiative

The multinational of hemoderivated Grifols, based in Barcelona (Spain), announced on Tuesday, January 14, 2025, the beginning of a study to detect early signs of Parkinson’s disease by analyzing plasma samples. In short... The entry Study of multinational Grifols to detect early signs of Parkinson’s disease in plasma was first published in Teleamazonas.

La multinacional de hemoderivados Grifols, con sede en Barcelona (España), ha anunciado este martes 14 de enero del 2025, el inicio de un estudio para detectar signos tempranos de la enfermedad de párkinson mediante el análisis de muestras de plasma. En resumen… La entrada Estudio de multinacional Grifols para detectar signos tempranos de párkinson en el plasma se publicó primero en Teleamazonas.

Grifols anuncia el estudio de signos tempranos de párkinson

Teleamazonas

Grifols Announces Early Signs of Parkinson’s Study

Market Consensus Link Securities  The Catalan haemoderivative company has received a $21 million grant from the Michael J. Fox Foundation for Parkinson's Disease Research (MJFF) to identify plasma-based biomarkers that could indicate a person's likelihood of developing Parkinson's disease (EP) "many years before" from his clinical diagnosis. The initiative, called "Chronos PD" in English, could accelerate the discovery of new diagnostic tools, a…

Consenso del Mercado Link Securities | La compañía catalana de hemoderivados ha recibido una subvención de $ 21 millones de la Fundación Michael J. Fox para la Investigación de la Enfermedad de Parkinson (MJFF) para identificar biomarcadores basados en plasma que podrían indicar la probabilidad de que una persona desarrolle la enfermedad de Parkinson (EP) «muchos años antes» de su diagnóstico clínico. La iniciativa, denominada «Chronos PD» en in…

Noticias Ibex 35 Grifols recibe una ayuda de 21 M$ de la Fundación Michael J. Fox para el descubrimiento de nuevas herramientas de diagnóstico del Parkinson

Consenso del Mercado

News Ibex 35 Grifols receives 21 M$ support from the Michael J. Fox Foundation for the discovery of new Parkinson’s diagnostic tools

The initiative, called "Chronos PD" in English, could accelerate the discovery of new diagnostic tools, as well as the identification and development of novel therapies that change the evolution of the disease. EP affects nearly a million people in the US and more than six million worldwide. It occurs when brain cells that produce dopamine, a chemical that coordinates the movement, cease to function or die. Despite decades of research and advanc…

La iniciativa, denominada "Chronos PD" en inglés, podría acelerar el descubrimiento de nuevas herramientas de diagnóstico, así como la identificación y desarrollo de terapias novedosas que modifiquen la evolución de la enfermedad. La EP afecta a casi un millón de personas en EEUU y a más de seis millones en todo el mundo. Ocurre cuando las células cerebrales que producen dopamina, una sustancia química que coordina el movimiento, dejan de funcio…

Grifols inicia un estudio con plasma para detectar signos tempranos del Parkinson

bolsamania.com

Grifols begins a plasma study to detect early signs of Parkinson’s

Grifols has been awarded a $21m grant from the Michael J Fox Foundation to find plasma biomarkers to predict Parkinson's years before symptoms start

Pharmaphorum

Grifols gets $21m award for Parkinson's biomarker hunt

The aim of the study is to analyze the composition and concentration of plasma that causes age and disease. The multinational of hemoderivated Grifols, based in Barcelona, Spain, announced the beginning of a study to detect early signs of Parkinson’s disease by analyzing plasma samples. The project, called ‘Chronos PD’, seeks biological signs that may indicate a greater probability of developing Parkinson’s disease years before symptoms appear, …

El objetivo del estudio es analizar la composición y la concentración del plasma que provoca la edad y las enfermedades. La multinacional de hemoderivados Grifols, con sede en Barcelona (España), anunció el inicio de un estudio para detectar signos tempranos de párkinson mediante el análisis de muestras de plasma. El proyecto, bautizado ‘Chronos PD’, busca señales biológicas que puedan indicar una mayor probabilidad de desarrollar la enfermedad …

Nuevo estudio busca identificar signos tempranos de párkinson mediante muestras de plasma

cablenoticias.tv

New study seeks to identify early signs of Parkinson using plasma samples

The funding will test a structured listener training program in a clinical trial with Parkinson’s patients and their communication partners.

Parkinson's News Today

Listener training study wins NIH grant to help Parkinson's...

Initiative aims to identify plasma-based biomarkers for early detection

Michael J. Fox funds early warning Parkinson's biomarker initiative

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics